GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » Market Cap

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Market Cap : ¥2,918.9 Mil (As of Jun. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Wuhan Hiteck Biological Pharma Co's share price for the quarter that ended in Mar. 2024 was ¥25.86. Wuhan Hiteck Biological Pharma Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 130.9 Mil. Therefore, Wuhan Hiteck Biological Pharma Co's market cap for the quarter that ended in Mar. 2024 was ¥3,384.9 Mil.

Wuhan Hiteck Biological Pharma Co's quarterly market cap declined from Sep. 2023 (¥5,013.2 Mil) to Dec. 2023 (¥4,726.6 Mil) and declined from Dec. 2023 (¥4,726.6 Mil) to Mar. 2024 (¥3,384.9 Mil).

Wuhan Hiteck Biological Pharma Co's annual market cap declined from Dec. 2021 (¥7,272.5 Mil) to Dec. 2022 (¥4,322.5 Mil) but then increased from Dec. 2022 (¥4,322.5 Mil) to Dec. 2023 (¥4,726.6 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Wuhan Hiteck Biological Pharma Co's Enterprise Value for Today is ¥1,874.0 Mil.


Wuhan Hiteck Biological Pharma Co Market Cap Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co Market Cap Chart

Wuhan Hiteck Biological Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,109.95 4,225.15 7,272.51 4,322.48 4,726.58

Wuhan Hiteck Biological Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,836.53 5,014.55 5,013.24 4,726.58 3,384.92

Competitive Comparison of Wuhan Hiteck Biological Pharma Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Wuhan Hiteck Biological Pharma Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Hiteck Biological Pharma Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wuhan Hiteck Biological Pharma Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Wuhan Hiteck Biological Pharma Co's Market Cap falls into.



Wuhan Hiteck Biological Pharma Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Wuhan Hiteck Biological Pharma Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥36.11*130.894
=¥4,726.6

Wuhan Hiteck Biological Pharma Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥25.86*130.894
=¥3,384.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Hiteck Biological Pharma Co  (SZSE:300683) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Wuhan Hiteck Biological Pharma Co Market Cap Related Terms

Thank you for viewing the detailed overview of Wuhan Hiteck Biological Pharma Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Hiteck Biological Pharma Co (SZSE:300683) Business Description

Traded in Other Exchanges
N/A
Address
Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Executives
Yan Jie Director
Li Sheng Qiang Executives

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Headlines

No Headlines